Getinge AB
STO:GETI B

Watchlist Manager
Getinge AB Logo
Getinge AB
STO:GETI B
Watchlist
Price: 189.3 SEK 1.42%
Market Cap: 51.6B SEK
Have any thoughts about
Getinge AB?
Write Note

Intrinsic Value

The intrinsic value of one GETI B stock under the Base Case scenario is 266.56 SEK. Compared to the current market price of 189.3 SEK, Getinge AB is Undervalued by 29%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

GETI B Intrinsic Value
266.56 SEK
Undervaluation 29%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Getinge AB

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for GETI B cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about GETI B?
Bearish
Neutral
Bullish
Discover Undervalued Stocks
Health Care Industry

Fundamental Analysis

Risks & Rewards

 

 

 

 

View All Risks & Rewards
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Notes
AI Assistant
AI Assistant
Ask me anything about Getinge AB

Provide an overview of the primary business activities
of Getinge AB.

What unique competitive advantages
does Getinge AB hold over its rivals?

What risks and challenges
does Getinge AB face in the near future?

Has there been any significant insider trading activity
in Getinge AB recently?

Summarize the latest earnings call
of Getinge AB.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Getinge AB.

Provide P/S
for Getinge AB.

Provide P/E
for Getinge AB.

Provide P/OCF
for Getinge AB.

Provide P/FCFE
for Getinge AB.

Provide P/B
for Getinge AB.

Provide EV/S
for Getinge AB.

Provide EV/GP
for Getinge AB.

Provide EV/EBITDA
for Getinge AB.

Provide EV/EBIT
for Getinge AB.

Provide EV/OCF
for Getinge AB.

Provide EV/FCFF
for Getinge AB.

Provide EV/IC
for Getinge AB.

Show me price targets
for Getinge AB made by professional analysts.

What are the Revenue projections
for Getinge AB?

How accurate were the past Revenue estimates
for Getinge AB?

What are the Net Income projections
for Getinge AB?

How accurate were the past Net Income estimates
for Getinge AB?

What are the EPS projections
for Getinge AB?

How accurate were the past EPS estimates
for Getinge AB?

What are the EBIT projections
for Getinge AB?

How accurate were the past EBIT estimates
for Getinge AB?

Compare the revenue forecasts
for Getinge AB with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Getinge AB and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Getinge AB against its competitors.

Analyze the profit margins
(gross, operating, and net) of Getinge AB compared to its peers.

Compare the P/E ratios
of Getinge AB against its peers.

Discuss the investment returns and shareholder value creation
comparing Getinge AB with its peers.

Analyze the financial leverage
of Getinge AB compared to its main competitors.

Show all profitability ratios
for Getinge AB.

Provide ROE
for Getinge AB.

Provide ROA
for Getinge AB.

Provide ROIC
for Getinge AB.

Provide ROCE
for Getinge AB.

Provide Gross Margin
for Getinge AB.

Provide Operating Margin
for Getinge AB.

Provide Net Margin
for Getinge AB.

Provide FCF Margin
for Getinge AB.

Show all solvency ratios
for Getinge AB.

Provide D/E Ratio
for Getinge AB.

Provide D/A Ratio
for Getinge AB.

Provide Interest Coverage Ratio
for Getinge AB.

Provide Altman Z-Score Ratio
for Getinge AB.

Provide Quick Ratio
for Getinge AB.

Provide Current Ratio
for Getinge AB.

Provide Cash Ratio
for Getinge AB.

What is the historical Revenue growth
over the last 5 years for Getinge AB?

What is the historical Net Income growth
over the last 5 years for Getinge AB?

What is the current Free Cash Flow
of Getinge AB?

Discuss the annual earnings per share (EPS)
trend over the past five years for Getinge AB.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Getinge AB

Current Assets 16.5B
Cash & Short-Term Investments 2.3B
Receivables 7B
Other Current Assets 7.2B
Non-Current Assets 38.8B
Long-Term Investments 66m
PP&E 5.6B
Intangibles 32.2B
Other Non-Current Assets 941m
Current Liabilities 14.3B
Accounts Payable 2.3B
Other Current Liabilities 12.1B
Non-Current Liabilities 9.4B
Long-Term Debt 4.2B
Other Non-Current Liabilities 5.2B
Efficiency

Earnings Waterfall
Getinge AB

Revenue
33.3B SEK
Cost of Revenue
-17.9B SEK
Gross Profit
15.4B SEK
Operating Expenses
-11.1B SEK
Operating Income
4.3B SEK
Other Expenses
-1.7B SEK
Net Income
2.6B SEK

Free Cash Flow Analysis
Getinge AB

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

GETI B Profitability Score
Profitability Due Diligence

Getinge AB's profitability score is 54/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Free Cash Flow
Positive Revenue Growth Forecast
Positive Operating Income
54/100
Profitability
Score

Getinge AB's profitability score is 54/100. The higher the profitability score, the more profitable the company is.

GETI B Solvency Score
Solvency Due Diligence

Getinge AB's solvency score is 60/100. The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
Average Altman Z-Score
Short-Term Solvency
60/100
Solvency
Score

Getinge AB's solvency score is 60/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

GETI B Price Targets Summary
Getinge AB

There are no price targets for GETI B.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for GETI B?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for GETI B is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

GETI B Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Profile

Getinge AB Logo
Getinge AB

Country

Sweden

Industry

Health Care

Market Cap

51.6B SEK

Dividend Yield

2.32%

Description

Getinge AB is a medical technology company specializes in providing equipment, systems, operating rooms, intensive-care units to the healthcare and the life science industries. The company is headquartered in Goeteborg, Vastra Gotalands and currently employs 10,729 full-time employees. The firm provides hospitals and Life Science institutions with products and solutions aimed at improving clinical outcomes and optimizing workflows. The Company’s reporting segments have the following activities: Acute Care Therapies develops solutions for life-sustaining care in acute health conditions. Life Science offers a comprehensive range of equipment, technical expertise and prevention consultation contamination in pharmaceutical production, biomedical research, production of medical equipment and in various laboratory applications. Surgical Workflows offers products and services for the effective disinfection and sterilization of instruments used in operations, operating tables and others hardware for operating rooms and advanced IT systems for efficient and secure workflows in hospitals.

Contact

VASTRA GOTALANDS
Goeteborg
Lindholmspiren 7
+46103350000.0
www.getingegroup.com

IPO

1995-06-08

Employees

10 729

Officers

CEO, President & Director
Mr. Mattias Perjos M.Sc.
Chief Financial Officer
Ms. Agneta Palmer
Head of Investor Relations
Mr. Lars Mattsson
Executive Vice President of Sustainability, Legal & Compliance
Ms. Anna Romberg MSc Econ
Executive Vice President of Human Resources
Mr. Magnus Lundback Ph.D.
Chief Commercial Officer
Mr. Carsten Blecker
Show More
President of Surgical Workflows
Mr. Stephane Le Roy
President of Life Science
Mr. Eric Honroth
President of North America Region
Ms. Patricia A. Fitch
President of Acute Care Therapies
Ms. Elin Frostehav
Show Less

See Also

Discover More
What is the Intrinsic Value of one GETI B stock?

The intrinsic value of one GETI B stock under the Base Case scenario is 266.56 SEK.

Is GETI B stock undervalued or overvalued?

Compared to the current market price of 189.3 SEK, Getinge AB is Undervalued by 29%.

Back to Top